weight maintenance after semaglutide discontinuation of GLP-1 therapies Semaglutide GLP-1 Medical Weight Loss

the third object of the invention is to provide a delivery system effecting delivery of therapeutically effective amounts of a potent drug GHK-Cu at a steady-state delivery rate

Comparison of the active components of Aster tataricus from different regions and related processed products by ultrahigh performance liquid chromatography with tandem mass spectrometry

This approach allows direct observation of how dual versus triple receptor agonism produces different downstream metabolic outcomes

Huang PJ, Huang YC, Su MF, Yang TY, Huang JR, Jiang CP

For this study, MALE were defined as acute limb ischemia requiring thrombectomy or major amputation, and MACE were defined as myocardial infarction, stroke, acute ischemic heart disease, and heart failure